Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Capital Investment Advisors LLC

Capital Investment Advisors LLC lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 14.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 120,546 shares of the company's stock after selling 20,151 shares during the period. Capital Investment Advisors LLC's holdings in Cardinal Health were worth $14,257,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. State Street Corp raised its holdings in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after buying an additional 42,082 shares during the last quarter. Pacer Advisors Inc. lifted its stake in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock valued at $474,203,000 after buying an additional 191,568 shares during the period. ProShare Advisors LLC boosted its position in Cardinal Health by 5.1% during the second quarter. ProShare Advisors LLC now owns 1,759,299 shares of the company's stock worth $172,974,000 after acquiring an additional 85,247 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in Cardinal Health by 7.1% in the 2nd quarter. Renaissance Technologies LLC now owns 1,683,447 shares of the company's stock worth $165,517,000 after acquiring an additional 111,137 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. UBS Group raised their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a report on Monday, November 4th. Morgan Stanley raised their price target on Cardinal Health from $127.00 to $136.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. StockNews.com downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Finally, Barclays upped their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $133.29.

Cardinal Health Stock Down 0.6 %

Shares of Cardinal Health stock traded down $0.70 during trading hours on Monday, hitting $120.87. 1,642,843 shares of the company's stock traded hands, compared to its average volume of 2,178,130. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $126.23. The stock has a 50 day simple moving average of $119.88 and a 200-day simple moving average of $111.08. The company has a market cap of $29.25 billion, a PE ratio of 23.52, a PEG ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the previous year, the firm earned $1.73 earnings per share. The business's revenue was down 4.3% compared to the same quarter last year. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.67%. Cardinal Health's payout ratio is 39.30%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.